Computed Tomography Perfusion Identifies Patients With Stroke With Impaired Cardiac Function.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
02 2020
Historique:
pubmed: 4 1 2020
medline: 1 7 2020
entrez: 4 1 2020
Statut: ppublish

Résumé

Background and Purpose- Low left ventricular ejection fraction (LVEF) leads to worse outcomes after stroke. We hypothesized that the arterial input function (AIF) variability on perfusion computed tomography, especially the time between scan onset and end of AIF (SO-EndAIF), would reflect reduction of cardiac output. Methods- Retrospective analysis of consecutive stroke patients, who underwent computed tomography between January 2013 and September 2018, was performed in 2 parts. (1) To determine the correlation between SO-EndAIF and LVEF, all patients with a transthoracic echocardiogram performed ±6 months from the time of stroke were included. LVEF was dichotomized as either normal (≥50%) or decreased (<50%). (2) AIF was compared with hypoperfusion volume, defined as delay time >3 seconds and with clinical outcome measured using 3-month modified Rankin Scale. Results- A total of 732 ischemic stroke patients underwent computed tomography, 231 with transthoracic echocardiogram were included in part (1), 393 with outcome data were included in part (2). In part (1), 193/231 (83.5%) had normal LVEF (median 61%) and 38/231 (16.5%) decreased LVEF (median 39%). The low-LVEF group had significantly prolonged SO-EndAIF compared with normal-LVEF group (mean of 39.7 versus 26 second;

Identifiants

pubmed: 31896345
doi: 10.1161/STROKEAHA.119.027255
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

498-503

Auteurs

Carlos Garcia-Esperon (C)

From the Department of Neurology, John Hunter Hospital (C.G.-E., N.J.S., S.G., F.M., C.R.L.), University of Newcastle, Australia.
Hunter Medical Research Institute (C.G.-E., N.J.S., F.M., T.L., S.T., C.R.L., M.W.P.), University of Newcastle, Australia.

Neil J Spratt (NJ)

From the Department of Neurology, John Hunter Hospital (C.G.-E., N.J.S., S.G., F.M., C.R.L.), University of Newcastle, Australia.
Hunter Medical Research Institute (C.G.-E., N.J.S., F.M., T.L., S.T., C.R.L., M.W.P.), University of Newcastle, Australia.

Shyam Gangadharan (S)

From the Department of Neurology, John Hunter Hospital (C.G.-E., N.J.S., S.G., F.M., C.R.L.), University of Newcastle, Australia.

Ferdinand Miteff (F)

From the Department of Neurology, John Hunter Hospital (C.G.-E., N.J.S., S.G., F.M., C.R.L.), University of Newcastle, Australia.
Hunter Medical Research Institute (C.G.-E., N.J.S., F.M., T.L., S.T., C.R.L., M.W.P.), University of Newcastle, Australia.

Andrew Bivard (A)

Department of Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Australia (A.B., M.W.P.).

Thomas Lillicrap (T)

Hunter Medical Research Institute (C.G.-E., N.J.S., F.M., T.L., S.T., C.R.L., M.W.P.), University of Newcastle, Australia.

Shinya Tomari (S)

Hunter Medical Research Institute (C.G.-E., N.J.S., F.M., T.L., S.T., C.R.L., M.W.P.), University of Newcastle, Australia.

Christopher R Levi (CR)

From the Department of Neurology, John Hunter Hospital (C.G.-E., N.J.S., S.G., F.M., C.R.L.), University of Newcastle, Australia.
Hunter Medical Research Institute (C.G.-E., N.J.S., F.M., T.L., S.T., C.R.L., M.W.P.), University of Newcastle, Australia.

Mark W Parsons (MW)

Hunter Medical Research Institute (C.G.-E., N.J.S., F.M., T.L., S.T., C.R.L., M.W.P.), University of Newcastle, Australia.
Department of Neurology, Melbourne Brain Centre at the Royal Melbourne Hospital, University of Melbourne, Parkville, Australia (A.B., M.W.P.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH